| Dr Ann D Layton, MD | |
|
1401 Braden St, Jacksonville, AR 72076-3720 | |
| (501) 985-2537 | |
| (501) 241-2707 |
| Full Name | Dr Ann D Layton |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 26 Years |
| Location | 1401 Braden St, Jacksonville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700879970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | E2859 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center North Little Rock | North little rock, AR | Hospital |
| St Vincent Medical Center/north | Sherwood, AR | Hospital |
| Chi-st Vincent Infirmary | Little rock, AR | Hospital |
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group | 5698758803 | 139 |
News Archive
Many an injury will heal, but the damaged spinal cord is notoriously recalcitrant. There's new hope on the horizon, though. A team of researchers led by the University of South Carolina's Jeff Twiss just reported an innate repair mechanism in central nervous system axons that might be harnessed to regenerate nerves after brain or spinal cord injuries.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.
Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units.
› Verified 1 days ago
| Entity Name | St Vincent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
Many an injury will heal, but the damaged spinal cord is notoriously recalcitrant. There's new hope on the horizon, though. A team of researchers led by the University of South Carolina's Jeff Twiss just reported an innate repair mechanism in central nervous system axons that might be harnessed to regenerate nerves after brain or spinal cord injuries.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.
Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ann D Layton, MD 1401 Braden St, Jacksonville, AR 72076-3720 Ph: (501) 985-2537 | Dr Ann D Layton, MD 1401 Braden St, Jacksonville, AR 72076-3720 Ph: (501) 985-2537 |
News Archive
Many an injury will heal, but the damaged spinal cord is notoriously recalcitrant. There's new hope on the horizon, though. A team of researchers led by the University of South Carolina's Jeff Twiss just reported an innate repair mechanism in central nervous system axons that might be harnessed to regenerate nerves after brain or spinal cord injuries.
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.
Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units.
› Verified 1 days ago
Dr. Paul E. Valentin-stone, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Braden St, Jacksonville, AR 72076 Phone: 501-985-2537 Fax: 501-241-2707 | |
Dr. Valerie Mcnee, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Red Fox Ln, Jacksonville, AR 72076 Phone: 501-680-1055 | |
Rachel White, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1110 W Main St, Jacksonville, AR 72076 Phone: 501-982-2108 Fax: 501-982-4951 | |
Muhammad Younus Shajaat, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1400 Braden St, Jacksonville, AR 72076 Phone: 800-893-9698 | |
Andrea J Eberle, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1109 Burman Dr, Jacksonville, AR 72076 Phone: 501-982-7575 Fax: 501-982-7510 |